Stacey Stevens - Icad Sr. VP of Marketing and Strategy


USD 1.80  0.03  1.64%   

Ms. Stacey M. Stevens is President of the company. Ms. Stevens was Senior Vice President Marketing and Strategy of ICAD Inc., since June 2006. Prior to joining iCAD, Ms. Stevens experience included a variety of sales, business development, and marketing management positions with Philips Medical Systems, Agilent Technologies, Inc. and Hewlett Packards Healthcare Solutions Group . From February 2005 until joining the Company she was Vice President, Marketing Planning at Philips Medical Systems, where she was responsible for the leadership of all global marketing planning functions for Philips Healthcare Business. From 2003 to January 2005, she was Vice President of Marketing for the Cardiac and Monitoring Systems Business Unit of Philips where she was responsible for all marketing and certain direct sales activities for the Americas Field Operation. Prior to that, Ms. Stevens held several key marketing management positions in the Ultrasound Business Unit of HewlettPackardAgilent and Philips Medical Systems
Age: 50  SVP Since 2019  MBA    
603 882-5200
Stevens earned a Bachelor of Arts Degree in Political Science from the University of New Hampshire, and an MBA from Boston University’s Graduate School of Management.

Stacey Stevens Latest Insider Activity

Tracking and analyzing the buying and selling activities of Stacey Stevens against Icad stock is an integral part of due diligence when investing in Icad. Stacey Stevens insider activity provides valuable insight into whether Icad is net buyers or sellers over its current business cycle. Note, Icad insiders must abide by specific rules, including filing SEC forms every time they buy or sell Icad'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Icad Management Efficiency

Icad Inc has return on total asset (ROA) of (12.97) % which means that it has lost $12.97 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (28.22) %, meaning that it created substantial loss on money invested by shareholders. Icad management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities. As of November 26, 2022, Return on Investment is expected to decline to -27.57. In addition to that, Return on Average Assets is expected to decline to -20.6. Icad Current Assets are projected to increase significantly based on the last few years of reporting. The past year's Current Assets were at 50.31 Million. The current year Assets Non Current is expected to grow to about 16.4 M, whereas Asset Turnover is forecasted to decline to 0.55.
The company currently holds 3.16 M in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. Icad Inc has a current ratio of 3.13, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Icad until it has trouble settling it off, either with new capital or with free cash flow. So, Icad's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Icad Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Icad to invest in growth at high rates of return. When we think about Icad's use of debt, we should always consider it together with cash and equity.
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire. Icad operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 136 people. Icad Inc (ICAD) is traded on NASDAQ Exchange in USA and employs 136 people.

Icad Inc Leadership Team

Elected by the shareholders, the Icad's board of directors comprises two types of representatives: Icad inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Icad. The board's role is to monitor Icad's management team and ensure that shareholders' interests are well served. Icad's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Icad's outside directors are responsible for providing unbiased perspectives on the board's policies.
Elliot Sussman, Independent Director
Andrew Sassine, Director
Kevin Burns, President, CFO, COO, Treasurer and Secretary
Somu Subramaniam, Independent Director
Rakesh Patel, Director
Steven Rappaport, Independent Director
Jonathan Go, Sr. VP of RandD
Zack Kubow, IR Contact Officer
Scott Areglado, Vice President Controller
Michael Klein, Director
Stacey Stevens, Sr. VP of Marketing and Strategy
Anthony Ecock, Independent Director
Rachel Brem, Independent Director
Susan Wood, Director
Richard Christopher, CFO, Executive Vice President
Lawrence Howard, Chairman of the Board
Kenneth Ferry, CEO and Director
Robert Goodman, Director

Icad Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Icad a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Icad Investors Sentiment

The influence of Icad's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Icad. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Icad's public news can be used to forecast risks associated with investment in Icad. The trend in average sentiment can be used to explain how an investor holding Icad can time the market purely based on public headlines and social activities around Icad Inc. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Icad's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Icad's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Icad's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Icad.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Icad in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Icad's short interest history, or implied volatility extrapolated from Icad options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Icad Inc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Risk vs Return Analysis. Note that the Icad Inc information on this page should be used as a complementary analysis to other Icad's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.

Complementary Tools for Icad Stock analysis

When running Icad Inc price analysis, check to measure Icad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icad is operating at the current time. Most of Icad's value examination focuses on studying past and present price action to predict the probability of Icad's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Icad's price. Additionally, you may evaluate how the addition of Icad to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Is Icad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icad. If investors know Icad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
46.6 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Icad Inc is measured differently than its book value, which is the value of Icad that is recorded on the company's balance sheet. Investors also form their own opinion of Icad's value that differs from its market value or its book value, called intrinsic value, which is Icad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icad's market value can be influenced by many factors that don't directly affect Icad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icad's value and its price as these two are different measures arrived at by different means. Investors typically determine Icad value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.